Influenza Diagnostic Tests Market Overview with Demographic Data and Industry Growth Trends 2020-2025

The influenza diagnostic tests market is anticipated to witness considerable gains in the upcoming years owing to the increasing prevalence of influenza across the globe. The high risk of flu complications among the people with chronic diseases and people with weak immune systems will further foster influenza diagnostic tests market share. Additionally, the growing research funding to improve the efficacy of existing influenza diagnostics tests will enhance the industry outlook.

Increasing awareness about the availability of multiple diagnostic tests for early prevention and detection of influenza could broaden the business prospects for influenza diagnostic kit manufacturing companies. Global Market Insights, Inc., suggests that the influenza diagnostic tests market could touch USD 1.5 billion by the year 2025.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4242

Influenza A is more prevalent and serious as compared to other variants including influenza B and C. Being a communicable disease, the epidemic of influenza A gets rapidly spread by a potent virus mostly known as avian flu or bird flu. Hence the Increasing incidence of influenza A is anticipated to augment the global market growth. In 2018, influenza diagnostic tests market size for Type A was valued at USD 779.4 million.

The traditional diagnostic tests are more popular than other types as they utilize the respiratory samples to for faster detection of influenza A and B antigens. The Rapid Influenza Diagnostic Test (RIDT) segment will witness considerable gains on account of the minimal time taken to yield the diagnostics result. RIDT is very popular as it discloses the results in a relevant time slot of less than 15 minutes, which is expected to augment the market share. Influenza diagnostic tests including the overall traditional diagnostic methods is projected to grow at the rate 7.1% over the forecast period.

According to Centers for Disease Control and Prevention (CDC), influenza kills about 12,000 to 79,000 people of the US population per year. Owing to the increasing prevalence of influenza in the region, the U.S market was valued at USD 287.0 million in 2018. Furthermore, the presence of well-established healthcare industry consisting skilled medical professionals coupled with government initiatives to produce advanced technologies for delivering efficient results for influenza testing will continue escalating the influenza diagnostic tests market growth.

Some of the firms in the market include Extremity Medical, Zimmer Biomet Holdings, Stryker Corporation, Arthrex, Integra LifeSciences Holdings Corporation, Smith & Nephew Plc, Acumed LLC, Tornier N.V. and Wright Medical Technology.

Request for customization @ https://www.gminsights.com/roc/4242

Partial Chapter of the Table of Content

Chapter 4. Influenza Diagnostic Tests Market, By Influenza Type

4.1. Global influenza diagnostic tests industry share, by influenza type, 2018 & 2025

4.2. Type A Flu

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Type B Flu

4.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 5. Influenza Diagnostic Tests Market, By Test Type

5.1. Global influenza diagnostic tests market share, by test type, 2018 & 2025

5.2. Traditional diagnostic test

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.2.2. Rapid Influenza Diagnostic Test (RIDT)

5.2.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.2.3. Direct Fluorescent Antibody Test (DFAT)

5.2.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.2.4. Viral culture

5.2.4.1. Market size, by region, 2014 – 2025 (USD Million)

5.2.5. Serological assay

5.2.5.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Molecular diagnostic assay

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.3.2. RT-PCR

5.3.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3.3. Loop-mediated Isothermal Amplification-based Assay (LAMP)

5.3.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.3.4. Nucleic Acid Sequence-based Amplification Test (NASBAT)

5.3.4.1. Market size, by region, 2014 – 2025 (USD Million)

5.3.5. Simple Amplification-based Assay (SAMBA)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/influenza-diagnostic-tests-market